PT - JOURNAL ARTICLE AU - Xie, Junqing AU - Feng, Yuliang AU - Newby, Danielle AU - Zheng, Bang AU - Feng, Qi AU - Prats-Uribe, Albert AU - Li, Chunxiao AU - Wareham, Nicholas J AU - Paredes, R AU - Prieto-Alhambra, Daniel TI - Contribution of genetics and lifestyle to the risk of major cardiovascular and thromboembolic complications following COVID-19 AID - 10.1101/2022.10.26.22281547 DP - 2022 Jan 01 TA - medRxiv PG - 2022.10.26.22281547 4099 - http://medrxiv.org/content/early/2022/10/27/2022.10.26.22281547.short 4100 - http://medrxiv.org/content/early/2022/10/27/2022.10.26.22281547.full AB - Clinical determinants for cardiovascular and thromboembolic (CVE) complications of COVID-19 are well-understood, but the roles of genetics and lifestyle remain unknown. We performed a prospective cohort study using UK Biobank, including 25,335 participants with confirmed SARS-CoV-2 infection between March 1, 2020, and September 3, 2021. Outcomes were hospital-diagnosed atrial fibrillation (AF), coronary artery disease (CAD), ischemic stroke (ISS), and venous thromboembolism (VTE) within 90 days post-infection. Heritable risk was represented by validated polygenic risk scores (PRSs). Lifestyle was defined by a composite of nine variables. We estimated adjusted hazard ratios (aHR) and confidence intervals (CI) using Cox proportional hazards models. In the COVID-19 acute phase, PRSs linearly predicted a higher risk of AF (aHR 1.52 per standard deviation increase, 95% CI 1.39 to 1.67), CAD (1.59, 1.40 to 1.81), and VTE (1.30, 1.11 to 1.53), but not ISS (0.92, 0.64 to 1.33). A healthy lifestyle was associated with a substantially lower risk of post-COVID-19 AF (0.70, 0.53 to 0.92), CAD (0.64, 0.44 to 0.91), and ISS (0.28, 0.12 to0.64), but not VTE (0.82, 0.48 to 1.39), compared with an unhealthy lifestyle. No evidence for interactions between genetics and lifestyle was found. Our results demonstrated that population genetics and lifestyle considerably influence cardiovascular complications following COVID-19, with implications for future personalised thromboprophylaxis and healthy lifestyle campaigns to offset the elevated cardiovascular disease burden imposed by the ongoing pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMr Xie is funded through Jardine-Oxford Graduate Scholarship and a titular Clarendon Fund Scholarship. Dr Prats-Uribe has received funding from the Medical Research Council (MRC) [MR/K501256/1, MR/N013468/1]. Prof Prieto-Alhambra is funded through a National Institute of Health Research (NIHR) Senior Research Fellowship (grant SRF-2018-11-ST2-004), and received partial support from the Oxford NIHR Biomedical Research Centre.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received ethical approval from the UKBB Ethics Advisory Committee (EAC) under application 65397.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors